When sourcing analytical-grade neurochemical research compounds, laboratory investigators require absolute chemical purity, lot-to-lot consistency, and fully verifiable documentation. PX1 Research supplies high-purity Selank for in vitro and preclinical research applications, accompanied by third-party analytical certification.
When sourcing analytical-grade neurochemical research compounds, laboratory investigators require absolute chemical purity, lot-to-lot consistency, and fully verifiable documentation. PX1 Research supplies high-purity Selank for in vitro and preclinical research applications, accompanied by third-party analytical certification.
To buy Selank online for qualified laboratory research, researchers must partner with verified domestic suppliers providing lot-specific analytical documentation. High-purity Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) should be acquired strictly as a lyophilized peptide manufactured under American quality standards, accompanied by independent RP-HPLC and Mass Spectrometry validation confirming sequence identity, purities exceeding 98%, and sub-threshold endotoxin levels.
Navigating the procurement of synthetic regulatory peptides requires strict adherence to quality assurance standards. Investigators ordering the Selank research compound must ensure that chemical vendors adhere to strict quality control protocols, avoiding unverified overseas suppliers whose products frequently display batch variations, degradation products, or residual manufacturing impurities that compromise experimental integrity.
Selank is a synthetic heptapeptide designed as an engineered derivative of the naturally occurring immunomodulatory tetrapeptide Tuftsin (Thr-Lys-Pro-Arg). By appending a Pro-Gly-Pro tripeptide motif to the C-terminus of Tuftsin, molecular pharmacologists significantly enhanced the enzymatic stability and biological half-life of the core peptide sequence against endogenous peptidases.
The primary sequence of Selank is L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolyl-glycyl-L-proline (C33H57N11O9) with a nominal molecular weight of approximately 751.9 g/mol. In laboratory formulations, this heptapeptide sequence exhibits stable solubility in aqueous media and buffered research solutions. Understanding the spatial conformation and peptide bond stability of Selank remains a primary focus in neurochemical research evaluating peptide transport across blood-brain barrier models and structural interactions with neural receptor complexes across all research peptides.
Preclinical investigations demonstrate that Selank interacts directly and indirectly with central neurochemical signaling pathways. A principal focus of current in vitro literature centers on its regulatory effects on the gamma-aminobutyric acid (GABA) system. In vitro radioligand binding assays indicate that Selank does not bind directly to the primary GABA recognition site on GABA-A receptors; rather, allosteric modulatory effects have been observed, influencing receptor affinity and chloride channel kinetics in the presence of endogenous GABA.
Beyond GABAergic modulation, preclinical rodent models indicate that Selank administration influences the expression of neurotrophic factors, specifically Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in hippocampal and cortical tissues. Gene expression profiling in murine neuronal cell cultures has demonstrated rapid transcriptomic shifts following Selank exposure, showing upregulated expression of neurotrophin genes and altered mRNA encoding for various neurotransmitter receptors. Research into these molecular cascades continues to expand our understanding of peptide-mediated neuroplasticity in controlled experimental setups.
A distinct mechanism established in preclinical literature is Selank's capacity to inhibit membrane-bound enkephalin-degrading enzymes. In vitro enzymatic assays show that Selank suppresses the enzymatic activity of carboxypeptidase N and neutral endopeptidase (enkephalinase), enzymes responsible for the metabolic cleavage of endogenous enkephalins. By attenuating enkephalin degradation, Selank preserves endogenous opioid peptide concentrations in isolated tissue preparations, offering an intriguing avenue for neurochemical signaling studies.
Furthermore, reflecting its ancestral derivation from Tuftsin, preclinical animal research highlights Selank's immunomodulatory interactions. Animal models evaluating peripheral gene expression report that Selank modulates the expression of pro-inflammatory and anti-inflammatory cytokines, including Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha). These findings make Selank a dual-interest candidate for research projects spanning both neurobiology and neuroimmunology.
In neurochemical literature, Selank is frequently evaluated alongside other regulatory heptapeptides developed for central nervous system investigations. The most prominent comparator is Semax, an ACTH(4-10) structural analog (Met-Glu-His-Phe-Pro-Gly-Pro). While Selank is derived from the immunomodulatory peptide Tuftsin and operates primarily through GABAergic, enkephalinase, and neurotrophic modulation, Semax acts predominantly through melanocortin receptor modulation, neurotrophin expression, and dopaminergic/cholinergic pathways.
Additionally, structural modifications of both peptides have yielded specialized derivatives for targeted research applications. For instance, N-Acetyl Selank Amidate features N-terminal acetylation and C-terminal amidation, modifications intended to further enhance metabolic resistance against exopeptidases in enzymatic stability studies. Comparing these compounds alongside foundational Tuftsin derivative research allows laboratories to select the precise molecular profile needed for specific receptor binding, gene expression, or enzymatic stability assays.
When procurement officers and laboratory investigators buy Selank online, verifying analytical purity is paramount to prevent experimental confounding. Reliable research peptide suppliers must supply lot-specific Certificates of Analysis (COA) generated by accredited, independent laboratories utilizing standardized analytical testing methods.
Key analytical metrics required for high-purity research peptides include:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity by separating the primary target peptide from synthesis byproducts, truncated sequences, or protective group residues. Research-grade Selank must demonstrate HPLC purity exceeding 98.0%.
2. Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF: Confirms exact molecular weight and sequence identity against calculated theoretical values (751.9 g/mol), ruling out sequence errors or heavy metal contamination.
3. Endotoxin Testing (LAL Assay): Essential for cellular and tissue-culture research, quantitative bacterial endotoxin testing ensures the compound is free from lipopolysaccharides (LPS) that trigger spurious inflammatory responses in vitro.
To preserve structural integrity and prevent degradation, lyophilized Selank must be stored under optimal physical conditions immediately upon arrival. Lyophilized peptide vials should be maintained at -20°C for short-to-medium term storage, or at -80°C for long-term archiving, shielded from light exposure.
Reconstitution protocols in laboratory settings require strict aseptic handling within a laminar flow hood. For detailed laboratory procedures, consult our dedicated guide on peptide storage protocols. Typically, lyophilized Selank is reconstituted using sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on downstream assay compatibility. Reconstitution should involve gently swirling the solvent down the inner glass wall of the vial; mechanical agitation or vigorous shaking should be avoided to prevent shear-stress denaturation of the peptide chain. Once reconstituted, liquid solutions must be aliquoted to avoid repeated freeze-thaw cycles and stored continuously at 2°C to 8°C.
Selecting a domestic supplier for laboratory peptides drastically reduces supply chain risks, shipping delays, and regulatory compliance issues. PX1 Research operates state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) standards, utilizing an ISO 17025 accredited testing framework to ensure uncompromising lot traceability.
Every batch of Selank offered by PX1 Research originates from domestic USA manufacturing lines, undergoing multi-stage analytical screening prior to release. By maintaining strict control over synthesis, purification, lyophilization, and secondary packaging, PX1 Research provides academic, biotechnology, and institutional facilities with reference-standard materials optimized for highly reproducible experimental outcomes.
PX1 Research supports university departments, pharmaceutical contract research organizations (CROs), and independent biotechnology institutions requiring consistent access to standardized peptide stock. Orders placed Monday through Friday ship same-day directly from our primary distribution centers in California and Arizona.
For large-scale research projects or ongoing experimental series requiring standardized lot reservations, PX1 Research provides tailored procurement structures. Investigators seeking volume quantities, custom lyophilization parameters, or specific packaging configurations are encouraged to explore our dedicated bulk peptide procurement program to establish institutional accounts with dedicated account management and priority analytical fulfillment.
What is Selank classified as in scientific research?
Selank is a synthetic regulatory heptapeptide (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the immunomodulatory human tetrapeptide Tuftsin. It is classified strictly as a chemical compound for in vitro and laboratory research.
How is Selank purity verified by PX1 Research?
Every lot of Selank undergoes rigorous third-party testing at an ISO 17025 accredited laboratory. Purity is validated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure ≥98% purity, Mass Spectrometry (MS) to verify molecular weight, and Chromogenic LAL assays to confirm sub-threshold endotoxin levels.
How should lyophilized Selank be stored upon receipt?
Lyophilized Selank should be kept in a desiccated freezer at -20°C or -80°C for long-term stability. Upon reconstitution with sterile laboratory solvents, liquid aliquots must be stored at 2°C to 8°C and protected from excessive freeze-thaw cycles and light exposure.
What is the key difference between Selank and Semax in research?
While both are synthetic regulatory peptides developed for neurochemical research, Selank is a Tuftsin analog that targets GABAergic modulation, enkephalinase inhibition, and neurotrophic factor expression. Semax is an ACTH(4-10) analog operating primarily via melanocortin and neurotrophic signaling.
Does PX1 Research provide lot-specific Certificates of Analysis?
Yes. Every shipment of Selank includes access to full, lot-specific third-party Certificates of Analysis (COAs) displaying actual HPLC chromatograms, mass spectra, and endotoxin assay results.
What solvents are suitable for reconstituting Selank for in vitro assays?
Common laboratory solvents include sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS), or sterile 0.9% Normal Saline, chosen based on the compatibility requirements of the specific cell culture or enzymatic assay.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based facilities adhering to GMP guidelines. Orders ship directly from our primary fulfillment centers located in California and Arizona, with same-day shipping on orders placed Monday through Friday.
Can Selank be ordered in bulk or wholesale quantities for institutional labs?
Yes. Qualified academic institutions, CROs, and corporate research laboratories can place bulk orders or establish institutional supply accounts via the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.